SLARD 2026: Non-Conventional Tumor Prosthesis in Patient With Sequelae of Osteomyelitis in Hip .
OrthoEvidence Journal (OE Journal) - ACE Report
Epub Ahead of Print
One adolescent patient with avascular necrosis of the femoral head and severe hip dysfunction secondary to osteomyelitis was treated with proximal femoral metaphyseal resection and total hip arthroplasty (THA) using a modular tumor prosthesis. The primary outcome of interest was restoration of hip function and ambulation. Secondary outcomes included pain, muscle recovery, strength, and return to activities. Outcomes were assessed at 8 weeks and 3 months postoperatively. Overall, the results of the report revealed that the patient regained the ability to walk by 8 weeks with rehabilitation and was pain-free at 3 months with partial recovery of muscle strength and function. These findings suggest that modular tumor prostheses may be an effective salvage option for restoring function in patients with severe hip destruction secondary to osteomyelitis.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!